Despite the reported evidence of deleterious effects
of metabolic
acidosis (MA), the development of advanced treatment options for this
critical condition has not been explored much. Based on fundamental
research and clinical trials, correcting MA with bicarbonate anions
has a vast array of potential benefits. To achieve this objective,
herein, we report on cytocompatible, charged polyzwitterionic nanogels
(PZNGs) that can efficiently fix and release bicarbonate anions by
a controlled and sustained mechanism. Three different PZNGs were synthesized
using free radical polymerization with Pluronic F-127 as a non-ionic
surfactant. From dynamic light scattering analysis, the hydrodynamic
sizes (D
h) were found to be 68 ±
6, 120 ± 3, and 97 ± 9 nm for PZNG-1, PZNG-2, and PZNG-3,
respectively. The fixation of HCO3
– on PZNGs was done either by direct
reaction with NaHCO3 or by CO2 gas bubbling
into a dispersion of PZNGs, and the maximum loading efficiency was
found to be ∼87–95%. Accelerated stability studies showed
good stability for 30 days at 25 and 2–8 °C for the nanogels.
The cytocompatibility results of the PZNGs from the MTT assay and
the live–dead test confirm their non-toxicity, safety, and
potential for various biomedical applications. The in vitro drug release
profile revealed a sustained and controlled release pattern of HCO3
– with a
maximum of ∼90% cumulative release in 168 h. The Korsmeyer–Peppas
kinetic model suggests that the HCO3
– anion release was regulated by diffusion
of the anions and swelling of polymeric nanogels. In addition to the
fixation and sustained release mechanisms described, the PZNGs reported
here act as a simple and efficient carrier to deliver HCO3
– anions
for the treatment of MA with reduced complications.